Cargando…

Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life

BACKGROUND: Benign epilepsy with centrotemporal spikes (BECTS) is the most common type of childhood idiopathic focal epilepsy. BECTS is associated with pervasive cognitive deficits and behavior problems. While seizures can be easily controlled, it is crucial to select anti-epileptic drugs that do no...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wan-Ting, Yan, Xiu-Xian, Cheng, Da-Zhi, Zhang, Han-Zi, Ding, Ning, Xu, Ke-Ming, Zhou, Xin-Lin, Chen, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401795/
https://www.ncbi.nlm.nih.gov/pubmed/32649517
http://dx.doi.org/10.1097/CM9.0000000000000925
_version_ 1783566632051802112
author Liu, Wan-Ting
Yan, Xiu-Xian
Cheng, Da-Zhi
Zhang, Han-Zi
Ding, Ning
Xu, Ke-Ming
Zhou, Xin-Lin
Chen, Qian
author_facet Liu, Wan-Ting
Yan, Xiu-Xian
Cheng, Da-Zhi
Zhang, Han-Zi
Ding, Ning
Xu, Ke-Ming
Zhou, Xin-Lin
Chen, Qian
author_sort Liu, Wan-Ting
collection PubMed
description BACKGROUND: Benign epilepsy with centrotemporal spikes (BECTS) is the most common type of childhood idiopathic focal epilepsy. BECTS is associated with pervasive cognitive deficits and behavior problems. While seizures can be easily controlled, it is crucial to select anti-epileptic drugs that do not impair cognition, do not cause psychosocial effects, and improve the quality of life. Previous studies showed effects of oxcarbazepine (OXC) monotherapy on the cognitive and psychosocial profiles of patients with BECTS. Here, we studied the effects of OXC monotherapy on the neuropsychologic profiles and quality of life in patients with BECTS in China. METHODS: Thirty-one patients aged 6 to 12 years newly diagnosed with BECTS were recruited. A psychometric assessment was performed before and during the follow-up of OXC monotherapy with Cognitive Computerized Task Battery, Depression Self-Rating Scale for children, Screen for Child Anxiety Related Emotional Disorders, and Quality of Life in Epilepsy-31 (QOLIE-31). The results of the assessments were compared to explore the effect of OXC monotherapy in patients with BECTS. RESULTS: Thirty children with BECTS completed the study. Five of ten cognitive test scores improved after treatment via OXC monotherapy, including visual tracing (F = 14.480, P < 0.001), paired associated learning (language) (F = 6.292, P < 0.001), paired associated learning (number) (F = 9.721, P < 0.05), word semantic (F = 6.003, P < 0.05), and simple subtraction (F = 6.229, P < 0.05). Of the neuropsychology data concerning the quality of life, statistically significant improvements were observed in emotion (F = 4.946, P < 0.05), QOLIE-social (F = 5.912, P < 0.05), and QOLIE-total (F = 14.161, P < 0.001). CONCLUSIONS: OXC is safe and does not impair neuropsychologic functions, with no obvious mood burden on children with BECTS. Most importantly, OXC has positive impacts on children's perception of quality of life, especially in terms of happiness and life satisfaction.
format Online
Article
Text
id pubmed-7401795
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-74017952020-08-05 Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life Liu, Wan-Ting Yan, Xiu-Xian Cheng, Da-Zhi Zhang, Han-Zi Ding, Ning Xu, Ke-Ming Zhou, Xin-Lin Chen, Qian Chin Med J (Engl) Original Articles BACKGROUND: Benign epilepsy with centrotemporal spikes (BECTS) is the most common type of childhood idiopathic focal epilepsy. BECTS is associated with pervasive cognitive deficits and behavior problems. While seizures can be easily controlled, it is crucial to select anti-epileptic drugs that do not impair cognition, do not cause psychosocial effects, and improve the quality of life. Previous studies showed effects of oxcarbazepine (OXC) monotherapy on the cognitive and psychosocial profiles of patients with BECTS. Here, we studied the effects of OXC monotherapy on the neuropsychologic profiles and quality of life in patients with BECTS in China. METHODS: Thirty-one patients aged 6 to 12 years newly diagnosed with BECTS were recruited. A psychometric assessment was performed before and during the follow-up of OXC monotherapy with Cognitive Computerized Task Battery, Depression Self-Rating Scale for children, Screen for Child Anxiety Related Emotional Disorders, and Quality of Life in Epilepsy-31 (QOLIE-31). The results of the assessments were compared to explore the effect of OXC monotherapy in patients with BECTS. RESULTS: Thirty children with BECTS completed the study. Five of ten cognitive test scores improved after treatment via OXC monotherapy, including visual tracing (F = 14.480, P < 0.001), paired associated learning (language) (F = 6.292, P < 0.001), paired associated learning (number) (F = 9.721, P < 0.05), word semantic (F = 6.003, P < 0.05), and simple subtraction (F = 6.229, P < 0.05). Of the neuropsychology data concerning the quality of life, statistically significant improvements were observed in emotion (F = 4.946, P < 0.05), QOLIE-social (F = 5.912, P < 0.05), and QOLIE-total (F = 14.161, P < 0.001). CONCLUSIONS: OXC is safe and does not impair neuropsychologic functions, with no obvious mood burden on children with BECTS. Most importantly, OXC has positive impacts on children's perception of quality of life, especially in terms of happiness and life satisfaction. Wolters Kluwer Health 2020-07-20 2020-07-01 /pmc/articles/PMC7401795/ /pubmed/32649517 http://dx.doi.org/10.1097/CM9.0000000000000925 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Liu, Wan-Ting
Yan, Xiu-Xian
Cheng, Da-Zhi
Zhang, Han-Zi
Ding, Ning
Xu, Ke-Ming
Zhou, Xin-Lin
Chen, Qian
Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title_full Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title_fullStr Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title_full_unstemmed Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title_short Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
title_sort oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401795/
https://www.ncbi.nlm.nih.gov/pubmed/32649517
http://dx.doi.org/10.1097/CM9.0000000000000925
work_keys_str_mv AT liuwanting oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT yanxiuxian oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT chengdazhi oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT zhanghanzi oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT dingning oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT xukeming oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT zhouxinlin oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife
AT chenqian oxcarbazepinemonotherapyinchildrenwithbenignepilepsywithcentrotemporalspikesimprovesqualityoflife